NeuroSAFE in radical prostatectomy increases the rate of nerve-sparing surgery without affecting oncological outcome.
Margaretha A van der SlotMichael A den BakkerTamara S C TanSebastiaan RemmersMartijn B BusstraMelanie GanSjoerd KlaverJohn B W RietbergenCharlotte F KweldamMike KliffenKaren E HamoenLeo M BudelNatascha N T GoemaereJozien HellemanChris H BangmaMonique J RoobolG J L H Geert van Leendersnull nullPublished in: BJU international (2022)
NeuroSAFE enables more unilateral and bilateral NSS without negatively affecting surgical margin status and biochemical recurrence. This validation study provides a comprehensive overview of the implementation, evaluation and intra-operative decision making associated with NeuroSAFE in clinical practice.